Reply to "use of alternative reference standards and exempted species to evaluate the performance of the Vitek 2 GP67 cefoxitin/oxacillin screen for coagulase-negative staphylococci"

Affiliations

¹ Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
² Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA paul.edelstein@uphs.upenn.edu.

Comment

Kristen N Johnson et al. J Clin Microbiol. 2015 Jan.

. 2015 Jan;53(1):366.

doi: 10.1128/JCM.03023-14.

¹ Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
² Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA paul.edelstein@uphs.upenn.edu.

No abstract available

Comment on

Detection of methicillin-resistant coagulase-negative staphylococci by the Vitek 2 system.
Johnson KN, Andreacchio K, Edelstein PH. Johnson KN, et al. J Clin Microbiol. 2014 Sep;52(9):3196-9. doi: 10.1128/JCM.01162-14. Epub 2014 Jun 20. J Clin Microbiol. 2014. PMID: 24951799 Free PMC article.
Use of alternative reference standards and exempted species to evaluate the performance of the Vitek 2 GP67 cefoxitin/oxacillin screen for coagulase-negative staphylococci.
Dunne WM Jr, Griffith R, Shortridge V. Dunne WM Jr, et al. J Clin Microbiol. 2015 Jan;53(1):365. doi: 10.1128/JCM.02771-14. J Clin Microbiol. 2015. PMID: 25524765 Free PMC article. No abstract available.

1. John MA, Burden J, Stuart JI, Reyes RC, Lannigan R, Milburn S, Diagre D, Wilson B, Hussain Z. 2009. Comparison of three phenotypic techniques for detection of methicillin resistance in Staphylococcus spp. reveals a species-dependent performance. J Antimicrob. Chemother 63:493–496. doi:10.1093/jac/dkn527. - DOI - PubMed
1. Dunne WM Jr, Griffith R, Shortridge V. 2015. Use of alternative reference standards and exempted species to evaluate the performance of the Vitek 2 GP67 cefoxitin/oxacillin screen for coagulase-negative staphylococci. J Clin Microbiol 53:365. doi:10.1128/JCM.02771-14. - DOI - PMC - PubMed
1. Hung KH, Yan JJ, Lu YC, Chen HM, Wu JJ. 2011. Evaluation of discrepancies between oxacillin and cefoxitin susceptibility in coagulase-negative staphylococci. Eur J Clin Microbiol Infect Dis 30:785–788. doi:10.1007/s10096-011-1156-7. - DOI - PubMed
1. Frigatto EA, Machado AM, Pignatari AC, Gales AC. 2005. Is the cefoxitin disk test reliable enough to detect oxacillin resistance in coagulase-negative staphylococci? J Clin Microbiol 43:2028–2029. doi:10.1128/JCM.43.4.2028-2029.2005. - DOI - PMC - PubMed
1. Swenson JM, Tenover FC. 2005. Results of disk diffusion testing with cefoxitin correlate with presence of mecA in Staphylococcus spp. J Clin Microbiol 43:3818–3823. doi:10.1128/JCM.43.8.3818-3823.2005. - DOI - PMC - PubMed